# OnCo record nct06325748 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06325748/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06325748", "NCT06325748" ;
  schema:name "SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS"@en ;
  schema:description "A phase 1 trial of SENTI-202 run by Senti Biosciences, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06325748/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06325748> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/senti-202/> ;
  onco:companies <https://onco.cc/companies/senti-biosciences/> .
